Categories Earnings, Technology

Diebold (NYSE: DBD): Q3 2019 Earnings Snapshot

— Diebold Nixdorf (NYSE: DBD) reported a third-quarter 2019 adjusted loss of $0.06 per share versus a profit of $0.24 per share expected.

— Total net sales declined by 4% to $1.08 billion versus $1.1 billion expected. The results were impacted by persistent currency headwinds and certain slow economic activity, notably in Europe, which is hurting customer demand for Retail solutions.

Earnings Update by AlphaStreet

— Sales from Eurasia Banking declined by 7% while that from the Americas Banking increased by 6%. Total retail sales fell by 11%.

— Looking ahead into the full year 2019, the company lowered its total revenue outlook to about $4.4 billion from the previous estimate of about $4.5 billion.

— Adjusted EBITDA is now expected to be in the range of $400 million to $410 million compared to the prior forecast range of $400 million to $420 million.

— Net cash provided by operating activities is now predicted to be in the $120 million to $150 million range, up from the earlier forecast of about $100 million.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

What to look for when CVS Health (CVS) reports Q3 earnings

Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain

eBay (EBAY): A few factors that helped drive growth in Q3 2024

Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,

CVX Earnings: Chevron reports lower revenue and profit for Q3 2024

Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top